pharmaphorum
FEBRUARY 27, 2023
Engaging digitally native healthcare professionals requires companies to challenge existing business ethos and commit to the customer experience in an increasingly digital world.
PharmaVoice
FEBRUARY 27, 2023
Staffing shortages are causing inefficiencies in clinical trials, but one leading CRO is finding ways to adapt.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
FEBRUARY 28, 2023
FDA turns down Cytokinetics’ once-promising heart failure drug omecamtiv kdunleavy Tue, 02/28/2023 - 18:55
Drug Topics
MARCH 3, 2023
Your weekly roundup of the latest news from Drug Topics®.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PhRMA
MARCH 2, 2023
Nearly all Americans nationwide agree: Lowering out-of-pocket costs for health care should be a top priority for policymakers. Luckily, there are commonsense policies Congress could implement to meaningfully address the cost burdens Americans face. These include things like making sure patients aren’t paying more for their medicines than their health insurance company or requiring first-dollar coverage, so insurance companies cover the cost of certain lifesaving medicines from day one of the pla
PharmaVoice
MARCH 1, 2023
As chief people officer, Dunkle is harnessing the company’s unique culture to foster innovation.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
MARCH 2, 2023
The pharmaceutical giant announced a 70% price reduction for most of its commonly sold insulin.
PhRMA
FEBRUARY 28, 2023
For over a decade, Rare Disease Day has been celebrated on February 28 to raise awareness and generate change for the more than 30 million patients in the U.S. living with a rare disease. This year’s Rare Disease Day is particularly special because this year also marks the 40 th anniversary of the Orphan Drug Act (ODA), allowing us to celebrate all the progress that’s come to patients because of it.
PharmaVoice
FEBRUARY 28, 2023
With more gene therapies headed to market, novel payment methods are emerging from regulators and academia.
STAT
MARCH 2, 2023
The costs of obesity are projected to soar globally, in step with rising prevalence, according to a new report from the World Obesity Federation, the only group focused solely on tracking global obesity trends and a partner of the World Health Organization. Over half the world’s population will be either overweight or have obesity by 2035, the report projected, while the economic impact of a high BMI could reach $4.32 trillion annually, if current trends continue and policy inertia around
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
FEBRUARY 27, 2023
A recent CDC report detailed the increased rates of sadness and violence among teenage girls.
PhRMA
MARCH 2, 2023
Health plans are increasingly using deductibles and coinsurance to shift more of the cost of care to chronically ill patients taking brand medicines. As data from IQVIA show, this alarming trend is especially burdensome for patients with cancer, who pay nearly 10X more on average per year for their medicines when they face deductibles and coinsurance versus patients with only fixed copays.
PharmaVoice
MARCH 2, 2023
With a focus on rare and hard-to-treat diseases, aTyr is banking on its head start in tRNA and vast IP portfolio to build a billion-dollar company.
Fierce Pharma
MARCH 1, 2023
Pfizer, Viatris and more must face 'overarching conspiracy' claims in generic price-fixing suit aliu Wed, 03/01/2023 - 10:03
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
MARCH 1, 2023
CMS has no plans to change their coverage and approval process, which the Alzheimer's Association believes is standing between patients and treatment.
PhRMA
FEBRUARY 28, 2023
Historically Black Colleges and Universities (“HBCUs”), federally designated as any college or university established prior to 1964 with the principal mission of educating Black Americans, play a pivotal role in the education of people of color and in our society. In 1837, Cheyney University of Pennsylvania made history by becoming the first Historically Black College and University (HBCU) in the United States.
PharmaVoice
MARCH 3, 2023
How some of our past PharmaVoice 100 honorees are transforming the life sciences industry in new roles.
STAT
FEBRUARY 28, 2023
Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Click on each matchup for a short summary of each school’s pioneering research. Then pick your favorites. Help us crown a champ!
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
MARCH 1, 2023
How can technology help pharmacists manage inventory—and the associated costs?
PhRMA
MARCH 1, 2023
The United States Patent and Trademark Office (USPTO) and the U.S. Food and Drug Administration (FDA) are in the process of considering new collaboration initiatives aimed at biopharmaceutical patents. As outlined in a recent public statement and written comments , PhRMA appreciates the agencies seeking public participation on important innovation policy issues and we strongly support the agencies stated commitment to “ensuring our innovation system strikes the appropriate balance—encouraging me
Fierce Healthcare
FEBRUARY 27, 2023
DEA's proposed telehealth rules pull back COVID-era remote prescribing flexibilities aburky Mon, 02/27/2023 - 14:17
PharmaVoice
MARCH 2, 2023
Zachary Roberts joined Allogene at the beginning of this year to lead the company's R&D and bring allogeneic cell therapy to the forefront.
Drug Topics
MARCH 1, 2023
The DEA is hoping to expand health care accessibility while also safeguarding from incorrectly prescribing medication.
STAT
FEBRUARY 26, 2023
On Friday, the Food and Drug Administration issued an emergency authorization for the first at-home test that can detect flu and Covid-19 — but for the test’s maker, Lucira, the long-anticipated authorization may have taken too long. The company filed for bankruptcy on Feb. 22, directly blaming the “protracted” FDA authorization process for the over-the-counter combination test for its financial troubles.
Fierce Healthcare
FEBRUARY 28, 2023
Experts push to remove barriers for physician-owned hospitals fdiamond Tue, 02/28/2023 - 14:42
PharmaVoice
MARCH 1, 2023
A BMJ study found that spending on drug sales vastly outstripped spending on drug development.
Drug Topics
MARCH 3, 2023
Artificial intelligence has many applications in health care, but hurdles to widespread adoption remain.
Drug Store News
MARCH 3, 2023
Lilly also will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin.
Fierce Healthcare
FEBRUARY 28, 2023
Hospitals' margins ticked downward in January but are still better off than much of 2022 dmuoio Tue, 02/28/2023 - 15:07
PharmaVoice
FEBRUARY 28, 2023
The FDA’s longtime neuroscience head Billy Dunn stepped down, leaving industry reeling over how the agency’s new acting director could handle upcoming approval decisions.
Drug Topics
MARCH 3, 2023
Convatec’s InnovaBurn is the first product of its kind intended to help patients manage burns and wounds.
STAT
MARCH 2, 2023
Janice Morales-Ferrer is a planner. It’s helped her get ahead in her career and in raising three young kids. But it’s hard to plan when you’ve got a rare disease, especially one with no standard treatment regimen or predictable outcome. “I’m a data-driven person,” said the 46-year-old Boston area resident. “It’s frustrating for me to not be able to plan how long I can live for my kids.
Fierce Healthcare
MARCH 1, 2023
Cleveland Clinic closes Q4 strong but ultimately logs $1.
Expert insights. Personalized for you.
98 
Let's personalize your content